Role of Antibodies Against Glutamate Receptors and Double Stranded DNA in Epilepsy Patients

The investigators will check the serum of epilepsy patients for antibodies against glutamate receptors and double stranded DNA. They will characterise the patients (by the kind of epilepsy, autoimmune disease comorbidity, and cognitive profile).

Inclusion Criteria:

• 120 epilepsy patients from the epilepsy clinic and Emergency Room (ER)
• Controls: 100 patients with other neurological diseases and no epilepsy; and 30 healthy volunteers.